APA

Gordon K. B., Betts K. A., Sundaram M., Signorovitch J. E., Li J., Xie M., Wu E. Q. & Okun M. M. (20171211). Poor early response to methotrexate portends inadequate long-term outcomes in patients with moderate-to-severe psoriasis: Evidence from 2 phase 3 clinical trials. : Journal of the American Academy of Dermatology.

Chicago

Gordon Kenneth B, Betts Keith A, Sundaram Murali, Signorovitch James E, Li Junlong, Xie Meng, Wu Eric Q and Okun Martin M. 20171211. Poor early response to methotrexate portends inadequate long-term outcomes in patients with moderate-to-severe psoriasis: Evidence from 2 phase 3 clinical trials. : Journal of the American Academy of Dermatology.

Harvard

Gordon K. B., Betts K. A., Sundaram M., Signorovitch J. E., Li J., Xie M., Wu E. Q. and Okun M. M. (20171211). Poor early response to methotrexate portends inadequate long-term outcomes in patients with moderate-to-severe psoriasis: Evidence from 2 phase 3 clinical trials. : Journal of the American Academy of Dermatology.

MLA

Gordon Kenneth B, Betts Keith A, Sundaram Murali, Signorovitch James E, Li Junlong, Xie Meng, Wu Eric Q and Okun Martin M. Poor early response to methotrexate portends inadequate long-term outcomes in patients with moderate-to-severe psoriasis: Evidence from 2 phase 3 clinical trials. : Journal of the American Academy of Dermatology. 20171211.